Fundraising Fox
Prologue Medicines
1 known investors
Find your way into Prologue Medicines
Prologue Medicines develops therapeutics derived from viral proteins, using a computational platform to mine the viral proteome for proteins that can modulate human physiology and treat disease. The company operates in the biotech and drug discovery field.
Investors · 1
Flagship Pioneeringlisted by Flagship PioneeringCambridge · $500K – $10M
How we know: Flagship Pioneering's portfolio page · a partner's Signal profile · funding news · biospace.com · Not right? Tell us
Funding
SEC filings, press & company announcements$50M disclosed across 1 round · 2024
- $50MraisedMay 2024 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Prologue Medicines do?
- Prologue Medicines develops therapeutics derived from viral proteins, using a computational platform to mine the viral proteome for proteins that can modulate human physiology and treat disease. The company operates in the biotech and drug discovery field.
- Who are Prologue Medicines's investors?
- Prologue Medicines's investors include Flagship Pioneering.
- How much funding has Prologue Medicines raised?
- Prologue Medicines has disclosed $50M raised across 1 round.